410 related articles for article (PubMed ID: 11844898)
1. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139
[TBL] [Abstract][Full Text] [Related]
3. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
Diener HC; McHarg A
Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
[TBL] [Abstract][Full Text] [Related]
5. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States.
Sheftell F; Ryan R; Pitman V;
Headache; 2003 Mar; 43(3):202-13. PubMed ID: 12603638
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks.
Stark R; Dahlöf C; Haughie S; Hettiarachchi J;
Cephalalgia; 2002 Feb; 22(1):23-32. PubMed ID: 11993610
[TBL] [Abstract][Full Text] [Related]
8. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Sandrini G; Färkkilä M; Burgess G; Forster E; Haughie S;
Neurology; 2002 Oct; 59(8):1210-7. PubMed ID: 12391349
[TBL] [Abstract][Full Text] [Related]
9. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
Färkkilä M; Olesen J; Dahlöf C; Stovner LJ; ter Bruggen JP; Rasmussen S; Muirhead N; Sikes C
Cephalalgia; 2003 Jul; 23(6):463-71. PubMed ID: 12807526
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Zhang L; Hay JW
CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.
Mathew NT; Schoenen J; Winner P; Muirhead N; Sikes CR
Headache; 2003 Mar; 43(3):214-22. PubMed ID: 12603639
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on eletriptan in migraine.
McCormack PL; Keating GM
CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
[TBL] [Abstract][Full Text] [Related]
15. Eletriptan for acute migraine.
Smith LA; Oldman AD; McQuay HJ; Moore RA
Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
[TBL] [Abstract][Full Text] [Related]
16. Eletriptan: a review of its use in the acute treatment of migraine.
McCormack PL; Keating GM
Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
18. Eletriptan review.
Färkkilä M; Kallela M
Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
[TBL] [Abstract][Full Text] [Related]
19. Eletriptan.
Gawel MJ; Grujich NN
Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
[TBL] [Abstract][Full Text] [Related]
20. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
